NPR-B agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546523
SERIAL NO

12888556

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SHIRE ORPHAN THERAPIES GMBH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hawlisch, Heiko Berlin, DE 6 17
Hellberg, Mark R Arlington, US 124 1363
Hummel, Gerd Berlin, DE 22 178
Knaute, Tobias Berlin, DE 6 17
Osterkamp, Frank Berlin, DE 31 175
Reimer, Ulf Berlin, DE 17 62
Reineke, Ulrich Berlin, DE 34 219
Richter, Uwe Berlin, DE 36 225
Simon, Bernadett Bonn, DE 6 17
Specker, Edgar Berlin, DE 11 19
Woischnik, Markus Berlin, DE 7 50

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00